Tramadol hydrochloride - Med Map PDF

Preview

Summary

Medication ATI worksheet for Tramadol hydrochloride...

Description

ACTIVE LEARNING TEMPLATE:

Medication

Joseline landa tramadol hydrochloride-ConZip, Ultram, Ultram ER MEDICATION __________________________________________________________________________ CATEGORY CLASS ______________________________________________________________________ Opioid agonist, Opioid analgesic ST UDENT NAME _____________________________________

REVIEW MODULE CHAPTER ___________

PURPOSE OF MEDICATION

Expected Pharmacological Action

Binds with mu receptors and inhibits the reuptake of norepinephrine and serotonin, which may account for tramadol's analgesic effect.

Therapeutic Use

The medications therapeutic use is to treat patients with mild to severe pain

Complications CNS: Agitation, anxiety, asthenia, depression, dizziness, emotional lability, euphoria, fatigue, fever, hallucinations, headache, hypertonia, hypoesthesia, insomnia, lethargy, nervousness, paresthesia, restlessness, rigors, seizures, serotonin syndrome, somnolence, suicidal ideation, tremor, vertigo, weakness CV: Chest pain, orthostatic hypotension, prolonged QT interval, torsades de pointes, vasodilation EENT: Blurred vision, dry mouth, nasal or sinus congestion, sore throat, vision changes

Medication Administration : Adults with chronic pain not requiring rapid onset of analgesic effect- 25 mg daily in morning Adults not currently treated with immediate-release form of tramadol- 100 mg once daily

Contraindications/Precautions Acute or severe bronchial asthma in the absence of resuscitative equipment or unmonitored setting, alcohol intoxication; children under the age of 12; excessive use of central-acting analgesics, hypnotics, opioids, or other psychotropic drugs; hypersensitivity to tramadol or its components; known or suspected gastrointestinal obstruction, including paralytic ileus; postoperative management in children ages 12 to 18 following adenoidectomy and/or tonsillectomy; significant respiratory depression; use within 14 days of MAO inhibitor therapy

Interactions alpha blockers, CYP2D6 and CYP3A4 inhibitors, linezolid, lithium, MAO inhibitors, St. John's wort, selective serotonin and norepinephrine reuptake inhibitors, tricyclic antidepressants, triptans: Increased risk of serotonin syndrome amiodarone, cimetidine, clomipramine, CYP2D6 inhibitors (bupropion, fluoxetine, paroxetine), desipramine, fluphenazine, haloperidol, propafenone, quinidine, ritonavir, thioridazine: Decreased analgesia, increased adverse effects of tramadol

Evaluation of Medication Effectiveness

Medication seems to be effective but with a-lot of severe reactions; if not taken correctly

ACTIVE LEARNING TEMPLATES

Nursing Interventions Monitor patient for respiratory depression that could become lifethreatening quickly, especially when drug is initiated or dosage is increased. If patient develops respiratory depression, expect to give naloxone. Watch for seizures because naloxone may increase this risk. Take seizure precautions.

Client Education - Urge patient to follow prescribed dose limits and dosing intervals to prevent respiratory depression and seizures. Warn patient that excessive or prolonged use can lead to abuse, addiction, misuse, overdose, and possibly death. - Instruct patient prescribed extendedrelease form to swallow tablet whole and not to chew, crush, or split tablet. -Caution patient not to stop tramadol abruptly.

THERAPEU TIC P ROCEDURE

A7...